DEF 14A: Canopy Growth Faces Shareholder Vote on Director Elections and Executive Pay Amidst Strategic Transformation

Canopy Growth Corporation's upcoming annual general meeting on September 24, 2024, will address key proposals including director elections, auditor re-appointment, and an advisory vote on executive compensation, as the company continues its strategic shift towards a cannabis-focused, asset-light model.

Summary

• Canopy Growth Corporation is holding its Annual General Meeting of Shareholders on September 24, 2024, to vote on several key proposals.
• Shareholders will vote on the election of five director nominees, all of whom are current directors seeking re-election.
• The meeting will also include a vote to re-appoint PKF O'Connor Davies LLP as the company's auditor for the fiscal year ending March 31, 2025.
• An advisory (non-binding) vote will be held to approve the compensation of the company's named executive officers.
• The company highlights its Fiscal 2024 business performance, including organizational transformation, balance sheet actions, Canadian commercial advancement, international markets medical cannabis growth, continued leadership in vaporization via Storz & Bickel and advancing Canopy USA to offer shareholders unique access to U.S. market growth.
• In Fiscal 2024, Canopy Growth reduced cost of goods sold by 45% year-over-year and SG&A expenses by 33% compared to Fiscal 2023.
• The company completed the sale of seven properties for approximately C$155 million and reduced total debt by C$710M in Fiscal 2024.
• Canopy USA initiated the acquisitions of Wana and Jetty, with the acquisition of Mountain High Products LLC expected to close in Q2 Fiscal 2025.
• CEO David Klein's base salary was adjusted from US$975,000 to US$750,000 effective June 8th, 2024, to align with the company's size and market capitalization.
• The Board approved a performance-based bonus for NEOs, totaling 157.63% of target, based on exceeding Adjusted EBITDA and revenue targets.
• The meeting will be held virtually via live audio webcast, allowing shareholders to participate, ask questions, and vote online.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook, highlighting strategic achievements and financial improvements. However, it also acknowledges challenges and risks, resulting in a moderately positive sentiment score.

Positives

• Significant cost reductions achieved in Fiscal 2024, with a 45% decrease in cost of goods sold and a 33% decrease in SG&A expenses.
• Successful debt reduction of C$710M in Fiscal 2024, with no material debt maturing until March 2026.
• Advancement of Canopy USA strategy with acquisitions of Wana and Jetty, providing access to the U.S. market.
• Strong performance of Storz & Bickel, with a 9% year-over-year increase in net revenue driven by the Venty vaporizer.
• The company's Canada medical cannabis business revenues increased 10% in Fiscal 2024 vs prior year in a declining market environment.
• CEO David Klein's compensation package was adjusted to reflect the company's size and market capitalization, aligning with shareholder interests.

Negatives

• The Share price performance declined because of considerable volatility in the cannabis sector resulting from a multitude of factors, including, among others, poor supply discipline along the cannabis supply chain resulting in ballooning inventories despite facility rationalization amongst the larger licensed producers in Canada.
• Relative stock underperformance was even more pronounced given that prices of commodities have been elevated and rising since Fiscal 2021, supporting the S&P TSX performance causing a significant shift in investor sentiment on growth stocks like cannabis.

Risks

• The company operates in the highly regulated cannabis industry, which is subject to evolving laws and regulations.
• The company's future performance depends on the successful integration of acquisitions and the execution of its strategic plans.
• The company faces competition from other cannabis producers and companies in related industries.
• The company's financial results may be affected by fluctuations in currency exchange rates.
• The company's stock price may be volatile due to market conditions and investor sentiment.

Future Outlook

The company aims to emerge as a cannabis-focused, brand-led, and asset-light corporation positioned for strength and profitability across the Canadian and global cannabis markets.

Management Comments

• For Fiscal 2025, Mr. Klein approached the Compensation Committee with recommendations to align his compensation package to reflect the new Companys size, scale and market capitalization.
• These adjustments reflect ongoing efforts to optimize executive compensation structures that are in line with corporate objectives, market conditions, and shareholder interests.

Industry Context

The document reflects Canopy Growth's efforts to adapt to the evolving cannabis industry, including cost reductions, strategic acquisitions, and a focus on core markets. The company's actions align with broader industry trends of consolidation and efficiency improvements.

Comparison to Industry Standards

• The document mentions a peer group of companies used for compensation benchmarking, including Canada Goose Holdings Inc., Tilray Brands, Inc., and Green Thumb Industries Inc.
• The company's executive compensation practices are compared to those of similar-sized companies in the consumer discretionary, consumer staples, and pharmaceuticals industries.
• The document references the Horizons Marijuana Life Sciences Index ETF as a benchmark for stock performance.

Management Changes

Corporate Governance

Legal Proceedings

• On June 2, 2023, the Ontario Securities Commission issued a management cease trade order against David Klein, the CEO and Judy Hong, the CFO, as a result of the Default. The management cease trade order was lifted on June 27, 2023 following the filing of the Companys annual reports on Form 10-K for the fiscal years ended March 31, 2023 and 2022, which contained the Companys audited financial statements for the fiscal years ended March 31, 2023 and 2022, as well as restatements of the Prior Financial Statements.
• On May 19, 2020, Reitmans filed a petition with the Qubec Superior Court for the issuance of, and was granted on the same day, an initial order (the Initial Order) seeking the protection and the remedies offered by the Companies Creditors Arrangement Act, R.S.C. 1985, c. C 36 (the CCAA).

Related Party Transactions

• On November 2, 2017, Greenstar invested C$245 million in Canopy Growth in exchange for Shares and warrants.
• On November 1, 2018, CBG invested C$5.079 billion in Canopy Growth in exchange for Shares and warrants.
• On April 18, 2019, CBG, Greenstar and Canopy Growth entered into the second amended and restated investor rights agreement.
• On June 29, 2022, Greenstar entered into an exchange agreement with the Company, pursuant to which Greenstar agreed to exchange C$100 million principal amount of the Canopy Notes for 2,924,546 Shares.
• On April 14, 2023, Greenstar entered into an exchange agreement with the Company pursuant to which the Company agreed to purchase for cancellation the remaining C$100 million principal amount of Canopy Notes held by Greenstar in exchange for a cash payment and a promissory note (the CBI Note).
• On April 18, 2024, in connection with the approval of the Exchangeable Shares Resolution and the creation of the Exchangeable Shares, the Company entered into an Exchange Agreement (the Exchange Agreement) with Greenstar, pursuant to which Greenstar converted approximately C$81.2 million of principal amount of the C$100 million principal amount CBI Note into 9,111,549 Exchangeable Shares (the Note Exchange), calculated based on a price per Exchangeable Share equal to C$8.91.
• Concurrently with the Note Exchange, Greenstar and CBG (together with Greenstar, the CBG Group), exchanged all 17,149,925 Shares they collectively held for 17,149,925 Exchangeable Shares (the CBI Exchange) for no consideration pursuant to the terms of the Companys Articles of Incorporation, as amended in accordance with the Exchangeable Shares Resolution.

Stakeholder Impact

• Shareholders will have the opportunity to vote on key proposals and influence the direction of the company.
• Employees may be affected by changes in executive compensation and strategic decisions.
• Customers may benefit from the company's focus on product innovation and quality.
• Suppliers and creditors may be impacted by the company's financial performance and strategic partnerships.

Next Steps

• Shareholders are encouraged to participate in the Annual General Meeting on September 24, 2024.
• Shareholders are advised to vote on the proposals outlined in the proxy statement.
• The company will continue to execute its strategic plans and monitor market conditions.

Key Dates

Keywords

Canopy Growth, Annual General Meeting, Director Election, Executive Compensation, Auditor Re-Appointment, Cannabis, Cost Reduction, Debt Reduction, Canopy USA, Storz & Bickel, Wana, Jetty